5 Best Healthcare Stocks to Buy in 2022 According to Hedge Funds

2. Thermo Fisher Scientific Inc. (NYSE:TMO)

Number of Hedge Fund Holders: 101

Thermo Fisher Scientific Inc. (NYSE:TMO) is a Massachusetts-based firm which offers medical laboratory products, analytical instruments, and life sciences solutions. Its shares have recorded a 21.91% growth in the last 12 months as of May 27.

Investors were eager on Thermo Fisher Scientific Inc. (NYSE:TMO) at the close of the first quarter, where 101 hedge funds reported bullish bets on the company shares, as opposed to 95 hedge funds a quarter earlier. Ken Fisher’s Fisher Asset Management held 2.25 million shares of Thermo Fisher Scientific Inc. (NYSE:TMO) worth $1.33 billion, making it the firm’s largest Q1 shareholder.

For the quarter ending March, Thermo Fisher Scientific Inc. (NYSE:TMO) disclosed a revenue of $11.8 billion, above estimates by $1.16 billion. EPS was also recorded above market estimates by $1.04.

In February, Thermo Fisher Scientific Inc. (NYSE:TMO) announced a 15-year strategic collaboration agreement with Moderna (NASDAQ:MRNA) to enable large-scale manufacturing of the latter’s Spikevax Covid vaccine. Thermo Fisher in April also announced the opening of a technology manufacturing site in Utah, where the firm will produce high-quality tech and materials required for the development of breakthrough therapies and new vaccines.

ClearBridge Investments discussed Thermo Fisher Scientific Inc. (NYSE:TMO) in its Q4 2021 investor letter. Here’s what the fund had to say:

“Improving health remains a key impact theme for the portfolio, and over the past year or so we have increased our exposure to the health care sector, through the addition of Thermo Fisher Scientific, a leading health care tools company, a leading provider of fertility benefit management services to self-insured employers that offers a rare win-win-win for employers, employees, health systems, and doctors, with clear savings and quality improvements.”